This video focuses on the drug inclisiran (sold under the brand name Leqvio). To begin, we introduce small interfering RNA (siRNA) technology. We discuss how inclisiran utilizes siRNA technology to lower cholesterol levels while emphasizing on the siRNA technology since inclisiran is one of the first drugs to use siRNA. Lastly, we discuss the limitations and cost of inclisiran.
This video was created by McMaster University students Alliya Naseer, Sunny Singh, Karanvir Nayyar, and Nikhil Uppal in collaboration with the Demystifying Research McMaster Program.
References:
1. Arnold, N., & Koenig, W. (2022, September 10). PCSK9 inhibitor wars: How does inclisiran fit in with current monoclonal antibody inhibitor therapy? considerations for patient selection - current cardiology reports. SpringerLink. Retrieved March 7, 2023, from link.springer.com/article/10....
2. N. Schütze. Abstract RNA interference (RNAi) represents a mechanism invented by nature to protect the genome. In the past few years the field has emerged at a surprisingly high pace. The underlying molecular mechanism of gene silencing provides us with short interferi. Zamore, P. D., Voinnet, O., Tabara, H., Schwarz, D. S., Pasquinelli, A. E., Ketting, R. F., Jorgensen, R., Guo, S., Grishok, A., Denli, A. D., Brummelkamp, T. R., Bernstein, E., Caplen, N. J., Carmell, M. A., Dillin, A., Doench, J. G., Dykxhoorn, D. M., … Gonczy, P. (2003, December 17). Sirna technology. Molecular and Cellular Endocrinology. Retrieved March 7, 2023, from www.sciencedirect.com/science...
3. British Heart Foundation. (2021, January 10). Inclisiran: Top questions on the new cholesterol-lowering drug. BHF. Retrieved March 7, 2023, from www.bhf.org.uk/informationsup....
4. Coveney, R. D. R. by S. (2021, May 13). What is Sirna? News. Retrieved March 7, 2023, from www.news-medical.net/life-sci...
5. Hu, B., Zhong, L., Weng, Y., Peng, L., Huang, Y., Zhao, Y., & Liang, X.-J. (2020, June 19). Therapeutic sirna: State of the art. Nature News. Retrieved March 7, 2023, from www.nature.com/articles/s4139...
6. Hypercholesterolemia - Symptoms, diagnosis and treatment | BMJ Best Practice US. Retrieved March 7, 2023, from bestpractice.bmj.com/topics/e....
7. National Center for Biotechnology Information. Retrieved March 8, 2023, from www.ncbi.nlm.nih.gov/books/NB...
8. Nishikido, T. (2023, January 30). Clinical potential of Inclisiran for patients with a high risk of atherosclerotic cardiovascular disease - cardiovascular diabetology. BioMed Central. Retrieved March 7, 2023, from cardiab.biomedcentral.com/art...
9. Novartis to acquire the Medicines Company for USD 9.7 bn, adding Inclisiran, a potentially transformational investigational cholesterol-lowering therapy to address leading global cause of death. Novartis. (2019, November 24). Retrieved March 7, 2023, from www.novartis.com/news/media-r...